PET in Oncology — Clinical Demands

  • Maike de Wit
Part of the Developments in Nuclear Medicine book series (DNUM, volume 28)


In industrialized countries the incidence of cancer is steadily increasing and ranks now second as a cause of death. New techniques are therefore needed to optimize diagnosis of malignant disorders. While high resolution computed tomography (CT) and magnetic resonance imaging (MRI) have improved the ability to detect changes in size or shape of physiological structures, it has become even more difficult to judge the significance of such findings.


Fine Needle Aspiration Cytology High Resolution Compute Tomography Bronchogenic Carcinoma Solitary Pulmonary Nodule Germ Cell Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boring CC, Squires TS, Tong T. Cancer Statistics, 1993. Cancer J Clin 1993; 43: 726.CrossRefGoogle Scholar
  2. 2.
    Freedman AS, Nadler LM. Non-Hodgkin’s Lymphomas. In: Holland JF, Frei E III, Bast RC, Kufe DW, Morton DL, Wechselbaum RR, editors. Cancer Medicine. Philadelphia, London: Lea and Felbinger, 1993: 2028–68.Google Scholar
  3. 3.
    Takvorian T, Canellos G. Hodgkin’s Disease. In: Holland JF, Frei E III, Bast RC, Kufe DW, Morton DL, Wechselbaum RR, editors. Cancer Medicine. Philadelphia, London: Lea and Felbinger, 1993: 1998–2027.Google Scholar
  4. 4.
    Sandrock D, Lastoria S, Magrath IT, et al. The role of gallium-67 tumour scintigraphy in patients with small, non cleaved cell lymphoma. Eur J Nucl Med 1993; 20: 119–22.PubMedCrossRefGoogle Scholar
  5. 5.
    Diehl V. HD-7 Protokoll der Deutschen Hodgkin Studiengruppe. Köln: Universitäts-klinik Köln, 1994: 23.Google Scholar
  6. 6.
    Hill M, Cunningham D, Macvivar D, et al. Role of magnetic resonance imaging in pre-dicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 1993; 11: 2273–78.PubMedGoogle Scholar
  7. 7.
    Newman JS, Francis IR, Kaminski MS, et al. Imaging of lymphoma with PET with 2- (F-18)-Fluoro-2-deoxy-D-glucose: Correlation with CT. Radiology 1994; 190: 111–16.PubMedGoogle Scholar
  8. 8.
    Blijham GH. Kolorektales Karzinom. In: Seeber S, Schütte J, editors. Therapiekonzepte Onkologie. Berlin, Heidelberg, New York: Springer-Verlag, 1993: 191–200.Google Scholar
  9. 9.
    Minton JP, Hoehne JL, Gerber DM, et al. Results of a 400-patients carcinoembryogenic antigen second-look colorectal cancer study. Cancer 1985; 55: 1285–90.Google Scholar
  10. 10.
    Fantini GA, DeCosse JJ. Surveillance strategies after resection of carcinoma of thecolon and rectum. Surg Gynecol Obstet 1990; 171: 267–73.PubMedGoogle Scholar
  11. 11.
    Strauss LG. Application of positron emission tomography in colorectal carcinoma.Onkologie 1993; 16: 232–44.CrossRefGoogle Scholar
  12. 12.
    Midthum DE, Swensen SJ, Jett JR. Clinical strategies for solitary pulmonary nodule.Ann Rev Med 1992; 43: 195–208.CrossRefGoogle Scholar
  13. 13.
    Levine MS, Weiss JD, Harrell JH, et al. Transthoracic needle aspiration biopsy follow-ing negative fiberoptic bronchoscopy in solitary pulmonary nodules. Chest 1988; 93: 1152–55.PubMedCrossRefGoogle Scholar
  14. 14.
    Khouri NF, Stitik FP, Erozan YS, et al. Transthoracic needle biopsy of the benign and malignant lung lesions. Am J Roentgenol 1985; 144: 281–88.Google Scholar
  15. 15.
    Utz JP, Patel AM, Edell ES. The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. Chest 1993; 104: 1012–1016.PubMedCrossRefGoogle Scholar
  16. 16.
    Swensen SJ, Harms GF, Morin RL, Myers JL. CT evaluation of solitary pulmonarynodules: Value of 185-H Reference phantom. Am J Roentgenol 1991; 156: 925–29.Google Scholar
  17. 17.
    Kubota K, Matsuzawa TM, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med 1990; 31: 1927–33.PubMedGoogle Scholar
  18. 18.
    Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993; 104: 997–1002.PubMedCrossRefGoogle Scholar
  19. 19.
    McLoud TM, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: Analy-sis of staging in the mediastinum with CT by correlative lymph node mapping andsampling. Radiology 1992; 182: 319–23.PubMedGoogle Scholar
  20. 20.
    Rubin E, Sanders C, Harvey JC, et al. Diagnostic imaging and staging of primary lungcancer. Semin Surg Oncol 1993; 9: 85–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Bülzebruck H, Bopp R, Drings P, et al. New aspects in the staging of lung cancer. Cancer 1992; 70: 1102–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the pattern of failureon patients with unresectable non-oat cell carcinoma of the lung treated with definiteradiotherapy. Cancer 1987; 59: 1874–81.PubMedCrossRefGoogle Scholar
  23. 23.
    Roth BJ, Nichols CR, Einhorn LH. Neoplasms of the testis. In: Holland JF, Frei E III, Bast RC, Kufe DW, Morton DL, Wechselbaum RR, editors. Cancer Medicine. Phila-delphia, London: Lea and Felbinger, 1993: 1592–1619.Google Scholar
  24. 24.
    Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemo-therapy in favorable-prognosis disseminated germ cell tumors: A Southeastern cancer study group protocoll. J Clin Oncol 1989; 7: 387–91.PubMedGoogle Scholar
  25. 25.
    Rosenthal MA, Stuart-Harris R, Tiver KW, et al. Single institutional experience with non-seminomatous germ cell tumours of the testis: local perspectives on a curable cancer. Aust NZ J Med 1991; 21: 857–62.CrossRefGoogle Scholar
  26. 26.
    Sagalowski AI, Ewalt DH, Molberg K, Peters PC. Predictors of residual mass histology after chemotherapy for advanced testis cancer. Urology 1990; 35: 537–42.CrossRefGoogle Scholar
  27. 27.
    Fossa SD, Qvist H, Stenwig AE, et al. Is postchemotherapy surgery necessary inpatients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol 1992; 10: 569–73.PubMedGoogle Scholar
  28. 28.
    Miller AB. Causes of breast cancer and high risk groups. In: Harris JR, Hellman S, Henderson IC, Kinne DW, editors. Breast diseases. Philadelphia: Lippincott, 1991: 119–26.Google Scholar
  29. 29.
    Burhenne LJ, Hislop TG, Burhenne HJ. The British Columbia Mammography Scree-ning Program: Evaluation of the first 15 months. Am J Roentgenol 1992; 158: 45–9.Google Scholar
  30. 30.
    Massod S, Frykberg ER, McLellan GL, et al. Prospective evaluation of radiologically directed fine needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990; 66: 1480–87.CrossRefGoogle Scholar
  31. 31.
    Zarbo RJ, Howanitz PI, Bachner P. Interinstitutional comparison of performance in breast fine-needle aspiration cytology. A Q-probe quality indicator. Arch Pathol Lab Med 1991; 115: 743–50.PubMedGoogle Scholar
  32. 32.
    Rotten D, Levaillant JM, Leridon H, et al. Ultrasonographically guided fine needle aspiration cytology and core needle biopsy in the diagnosis of breast tumors. Eur J Obstet Gynecol Reprod Biol 1993; 49: 175–86.PubMedCrossRefGoogle Scholar
  33. 33.
    Vetrani A, Fulciniti F, Di-Benedetto G, et al. Fine needle biopsies of breast masses. An additional experience with 1153 cases (1985 to 1988) and a meta-analysis. Cancer 1992; 69: 736–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Adler LP, Crowe JP, Al-Kaisi NK, et al. Evaluation of breast masses and axillary lymph nodes with (F-18)2-Deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187: 743–50.PubMedGoogle Scholar
  35. 35.
    Huvos A, Hutter V, Berg J. Significance of axillary macrometastases and micrometas-tases in mammary cancer. Ann Surg 1971; 1: 44–46.CrossRefGoogle Scholar
  36. 36.
    Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 1992; 216: 27–34.PubMedCrossRefGoogle Scholar
  37. 37.
    Garbe C, Orfanos CE. Epidemiology of malignant melanoma in Central Europe. Risk factors and prognostic predictors. Pigm Cell Res 1992; 5: 285–94.CrossRefGoogle Scholar
  38. 38.
    Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 cm or 3 cm. N Engl J Med 1989; 318: 1159–62.CrossRefGoogle Scholar
  39. 39.
    Balch CM, Milton GW, Cascinelli N, Sim HF. Elective lymph node dissection: pros and cons. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, editors. Cutaneous melanoma. Philadelphia: Lippincott, 1992: 345–66.Google Scholar
  40. 40.
    Gritters LS, Francis IR, Zasadny KR, et al. Initial assessment of Positron Emission Tomography using 2-Fluorine-18-Fluor-Deoxy-D-Glucose in the imaging of malignant melanoma. J Nucl Med 1993; 34: 1420–27.PubMedGoogle Scholar
  41. 41.
    Brambs HJ, Claussen CD. Pancreatic and ampullary carcinoma. Ultrasound, computed tomography, magnetic resonance imaging and angiography. Endoscopy 1993; 25: 58–68.PubMedCrossRefGoogle Scholar
  42. 42.
    Partanen PA, Partanen KP, Pikkarainen PH, et al. A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the diffe-rential diagnosis of benign and malignant jaundice and cholestasis. Eur J Surg 1993; 159: 23–29.PubMedGoogle Scholar
  43. 43.
    Grimm H, Maydeo A, Soehendra N. Endoluminal ultrasound for the diagnosing and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4: 869–88.PubMedCrossRefGoogle Scholar
  44. 44.
    Bares R, Klever P, Hellwig D, et al. Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results. Nucl Med Comm 1993; 14: 596–601.CrossRefGoogle Scholar
  45. 45.
    Paulson DF, Moul JW, Walther PJ, et al. Radical prostatectomy for clinical stage T1–2NOMO prostatic adenocarcinoma: Long term results. J Urol 1990; 144: 118–084.Google Scholar
  46. 46.
    Hammerer P, Huland H. Zur Diagnostik des lokalisierten Prostatakarzinoms: Screening and präoperatives Staging. Urologe A. 1991; 30: 378–86.PubMedGoogle Scholar
  47. 47.
    Rioja-Sanz C, Blas-Marin M, Rioja-Sans L. Laparoscopic pelvic lymphadenectomy in the staging of prostate cancer. Eur Urol 1993; 24: 19–21.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Maike de Wit

There are no affiliations available

Personalised recommendations